Correspondence 0001493152-24-032691 from MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286) (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286)
Date: Aug. 15, 2024 · CIK: 0001904286 · Accession: 0001493152-24-032691
AI Filing Summary & Sentiment
File numbers found in text: 333-281467
Letter
MIRA Pharmaceuticals, Inc.
Brickell Avenue, Suite 1950 #1183,
Miami, Florida 33131
August 15, 2024
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
Office of Life Sciences
F Street, N.E.
Washington, D.C. 20549
Re: MIRA Pharmaceuticals, Inc.
Registration Statement on Form S-3
File No. 333-281467
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, MIRA Pharmaceuticals, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on Friday, August 16, 2024, or as soon thereafter as possible.
* * * *
Very
Truly Yours,
MIRA
Pharmaceuticals, Inc.
Show Raw Text
CORRESP
1
filename1.htm
MIRA Pharmaceuticals, Inc.
1200
Brickell Avenue, Suite 1950 #1183,
Miami,
Florida 33131
August
15, 2024
VIA
EDGAR
U.S.
Securities & Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Re:
MIRA
Pharmaceuticals, Inc.
Registration
Statement on Form S-3
File
No. 333-281467
Ladies
and Gentlemen:
In
accordance with Rule 461 of the Securities Act of 1933, as amended, MIRA Pharmaceuticals, Inc. hereby respectfully requests that the
effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern
Time on Friday, August 16, 2024, or as soon thereafter as possible.
*
* * *
Very
Truly Yours,
MIRA
Pharmaceuticals, Inc.
/s/
Erez Aminov
Erez
Aminov
Chief
Executive Officer